Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Hepatocellular Carcinoma Disease Staging Systems by Incorporating Tumor Micronecrosis: A Multi-institutional Retrospective Study

NCT05739110 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05739110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05739110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Hepatocellular Carcinoma Disease Staging Systems by Incorporating Tumor Micronecrosis: A Multi-institutional Retrospective Study
Lead sponsor
Zhejiang University
Phase
Observational
Overall status
Completed
Start date
July 15, 2022
Completion date
January 15, 2023
Enrollment
1,100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma